The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(2aS,2a1S,5aS,6S,9aR)-2a-isopropyl-8-methyl-2-tosyldecahydro-6,9a-epoxyazepino[3,4,5-cd]indol-5(1H)-one ID: ALA5285915
Max Phase: Preclinical
Molecular Formula: C22H30N2O4S
Molecular Weight: 418.56
Associated Items:
Names and Identifiers Canonical SMILES: Cc1ccc(S(=O)(=O)N2C[C@@]34CN(C)C[C@@H](O3)[C@H]3C(=O)CC[C@]2(C(C)C)[C@H]34)cc1
Standard InChI: InChI=1S/C22H30N2O4S/c1-14(2)22-10-9-17(25)19-18-11-23(4)12-21(28-18,20(19)22)13-24(22)29(26,27)16-7-5-15(3)6-8-16/h5-8,14,18-20H,9-13H2,1-4H3/t18-,19-,20-,21-,22+/m1/s1
Standard InChI Key: NDKVYFWLWVQESG-LMYCIYFBSA-N
Molfile:
RDKit 2D
32 36 0 0 0 0 0 0 0 0999 V2000
-0.9212 1.8455 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
-0.2067 1.4330 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4064 0.8808 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8787 1.8679 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.4353 2.7677 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.1915 3.5559 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
-0.2067 2.2583 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2067 3.0833 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
-0.9214 2.6709 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.9214 3.4959 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.6361 2.2583 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.6361 1.4330 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.9214 1.0204 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.8418 0.8068 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4252 1.3902 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.0822 0.0176 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7498 0.2132 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.3332 -0.3701 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-2.1582 -0.3701 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.7465 0.3457 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.1197 -1.1669 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7056 -1.7528 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4875 -2.5480 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.6942 -2.7590 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.4807 -3.5559 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.1106 -2.1754 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3228 -1.3807 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0707 0.1269 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2401 2.5847 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6002 1.8456 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.4252 1.8456 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2402 1.1114 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 1
2 3 1 0
3 4 1 6
5 4 1 0
5 6 1 6
7 5 1 0
2 7 1 0
7 8 1 1
7 9 1 0
9 10 2 0
11 9 1 0
11 12 1 0
12 13 1 0
2 13 1 0
13 14 1 1
14 15 1 0
14 16 1 0
13 17 1 0
17 18 1 0
18 19 2 0
18 20 2 0
18 21 1 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 1 0
24 26 2 0
26 27 1 0
27 21 2 0
28 17 1 0
3 28 1 0
5 29 1 0
29 30 1 0
30 31 1 0
30 32 1 0
3 32 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 418.56Molecular Weight (Monoisotopic): 418.1926AlogP: 2.07#Rotatable Bonds: 3Polar Surface Area: 66.92Molecular Species: NEUTRALHBA: 5HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 6.04CX LogP: 2.44CX LogD: 2.42Aromatic Rings: 1Heavy Atoms: 29QED Weighted: 0.75Np Likeness Score: 0.15
References 1. Hassan H, Chiavaralli J, Hassan A, Bedda L, Krischuns T, Chen KY, Li ASM, Delpal A, Decroly E, Vedadi M, Naffakh N, Agou F, Mallart S, Arafa RK, Arimondo PB.. (2023) Design and synthesis of naturally-inspired SARS-CoV-2 inhibitors., 14 (3): [PMID:36970153 ] [10.1039/d2md00149g ]